Table 2.
Comorbidities and mortality among patients with CHIKV infection according to the occurrence of kidney disease. Fortaleza, Ceara, Brazil, 2016–2017
| CKD* (N = 691) | No-CKD (N = 177,240) | P | |
|---|---|---|---|
| Diabetes mellitus | 287 (41.5%) | 4,890 (2.8%) | < 0.0001 |
| Hematological disorders | 243 (35.2%) | 465 (0.3%) | < 0.0001 |
| Liver diseases | 247 (35.7%) | 516 (0.3%) | < 0.0001 |
| Hypertension | 394 (57.0%) | 11,821 (6.7%) | < 0.0001 |
| Peptic ulcer disease | 241 (34.9%) | 648 (0.4%) | < 0.0001 |
| Autoimmune diseases | 230 (33.3%) | 468 (0.3%) | < 0.0001 |
| Death | 19 (3.0%) | 364 (0.2%) | < 0.0001 |
CHIKV = chikungunya virus; CKD = chronic kidney disease.
Missing data: 88,065 (without information about CKD in the notification report).